• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种 SARS-CoV-2 抗体抑制病毒核衣壳蛋白诱导的补体过度激活。

A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation.

机构信息

Molecular Imaging Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.

Institute of Biomedicine, Jinan University, Guangzhou, China.

出版信息

Nat Commun. 2021 May 11;12(1):2697. doi: 10.1038/s41467-021-23036-9.

DOI:10.1038/s41467-021-23036-9
PMID:33976229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113585/
Abstract

Although human antibodies elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein are profoundly boosted upon infection, little is known about the function of N-reactive antibodies. Herein, we isolate and profile a panel of 32 N protein-specific monoclonal antibodies (mAbs) from a quick recovery coronavirus disease-19 (COVID-19) convalescent patient who has dominant antibody responses to the SARS-CoV-2 N protein rather than to the SARS-CoV-2 spike (S) protein. The complex structure of the N protein RNA binding domain with the highest binding affinity mAb (nCoV396) reveals changes in the epitopes and antigen's allosteric regulation. Functionally, a virus-free complement hyperactivation analysis demonstrates that nCoV396 specifically compromises the N protein-induced complement hyperactivation, which is a risk factor for the morbidity and mortality of COVID-19 patients, thus laying the foundation for the identification of functional anti-N protein mAbs.

摘要

虽然人类针对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)核衣壳(N)蛋白产生的抗体在感染后会被显著增强,但人们对 N 反应性抗体的功能知之甚少。在此,我们从一位快速康复的 COVID-19 患者中分离并鉴定了一组 32 种 N 蛋白特异性单克隆抗体(mAb),该患者对 SARS-CoV-2 N 蛋白的抗体反应强于对 SARS-CoV-2 刺突(S)蛋白的抗体反应。与具有最高结合亲和力的 mAb(nCoV396)的 N 蛋白 RNA 结合域的复合物结构揭示了表位和抗原变构调节的变化。功能上,无病毒补体超激活分析表明,nCoV396 特异性地破坏了 N 蛋白诱导的补体超激活,这是 COVID-19 患者发病率和死亡率的一个风险因素,从而为鉴定功能性抗 N 蛋白 mAb 奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/4927be01e05c/41467_2021_23036_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/d4f24441e1bb/41467_2021_23036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/2fd5604dc525/41467_2021_23036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/02631e6643c6/41467_2021_23036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/4927be01e05c/41467_2021_23036_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/d4f24441e1bb/41467_2021_23036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/2fd5604dc525/41467_2021_23036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/02631e6643c6/41467_2021_23036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/8113585/4927be01e05c/41467_2021_23036_Fig4_HTML.jpg

相似文献

1
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation.一种 SARS-CoV-2 抗体抑制病毒核衣壳蛋白诱导的补体过度激活。
Nat Commun. 2021 May 11;12(1):2697. doi: 10.1038/s41467-021-23036-9.
2
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.一种中和性人源抗体结合到了 SARS-CoV-2 的刺突蛋白的 N 端结构域。
Science. 2020 Aug 7;369(6504):650-655. doi: 10.1126/science.abc6952. Epub 2020 Jun 22.
3
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.针对 SARS-CoV-2 核衣壳表位具有特异性的 CD8 T 细胞表现出高的初始前体频率和 TCR 多样性。
Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15.
4
Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.开发针对严重急性呼吸综合征冠状病毒 2 的核衣壳蛋白的患者源性人单克隆抗体用于 2019 年冠状病毒病诊断。
Front Immunol. 2020 Nov 13;11:595970. doi: 10.3389/fimmu.2020.595970. eCollection 2020.
5
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
6
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.COVID-19 急性和恢复期患者对 SARS-CoV-2 膜蛋白的抗体反应。
Front Immunol. 2021 Aug 4;12:679841. doi: 10.3389/fimmu.2021.679841. eCollection 2021.
7
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.人源单克隆抗体对 SARS-CoV-2 蛋白与组织抗原的反应:对自身免疫性疾病的影响。
Front Immunol. 2021 Jan 19;11:617089. doi: 10.3389/fimmu.2020.617089. eCollection 2020.
8
Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective.从抗原角度看 SARS-CoV-2 感染的免疫检测。
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02160-20.
9
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.与单纯 SARS-CoV-2 感染的儿童相比,患有儿童多系统炎症综合征的儿童的 SARS-CoV-2 特异性 T 细胞反应更强。
Front Immunol. 2022 Jan 18;12:793197. doi: 10.3389/fimmu.2021.793197. eCollection 2021.
10
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.SARS-CoV-2 血清阳性率调查估计受到核衣壳抗体下降的影响。
J Infect Dis. 2021 Apr 23;223(8):1334-1338. doi: 10.1093/infdis/jiaa796.

引用本文的文献

1
The Role of SARS-CoV-2 Nucleocapsid Protein in Host Inflammation.严重急性呼吸综合征冠状病毒2核衣壳蛋白在宿主炎症中的作用
Viruses. 2025 Jul 27;17(8):1046. doi: 10.3390/v17081046.
2
Structural basis of a human antibody targeting SARS-CoV-2 nucleocapsid protein dimerization domain and interfering with RNA-binding.一种靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白二聚化结构域并干扰RNA结合的人源抗体的结构基础
Commun Biol. 2025 Aug 19;8(1):1248. doi: 10.1038/s42003-025-08648-x.
3
Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment.

本文引用的文献

1
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.基因组 RNA 元件驱动 SARS-CoV-2 核衣壳的相分离。
Mol Cell. 2020 Dec 17;80(6):1078-1091.e6. doi: 10.1016/j.molcel.2020.11.041. Epub 2020 Nov 27.
2
SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.SARS-CoV-2 核衣壳蛋白与 RNA 以及与人类 hnRNPs 相分离。
EMBO J. 2020 Dec 15;39(24):e106478. doi: 10.15252/embj.2020106478. Epub 2020 Dec 4.
3
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
通过与从病毒基因组片段设计的RNA序列结合,使内在无序的新冠病毒N蛋白实现结构稳定。
Nat Commun. 2025 Jul 15;16(1):6521. doi: 10.1038/s41467-025-61861-4.
4
Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein.抗SARS-CoV-2核衣壳蛋白抗体的保护潜力及功能作用
Antibodies (Basel). 2025 May 28;14(2):45. doi: 10.3390/antib14020045.
5
Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA.严重急性呼吸综合征冠状病毒2核蛋白的无亲和标签纯化及其与单链DNA复合物的晶体结构
Biomolecules. 2024 Nov 30;14(12):1538. doi: 10.3390/biom14121538.
6
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.在hACE2小鼠中,将含额外抗原的SARS-CoV-2 mRNA加强免疫与基于刺突蛋白的mRNA疫苗针对奥密克戎BA.5感染进行比较。
PLoS One. 2024 Dec 3;19(12):e0314061. doi: 10.1371/journal.pone.0314061. eCollection 2024.
7
Prone position ventilation-induced oxygenation improvement as a valuable predictor of survival in patients with acute respiratory distress syndrome: a retrospective observational study.俯卧位通气诱导的氧合改善是急性呼吸窘迫综合征患者生存的有价值的预测指标:一项回顾性观察研究。
BMC Pulm Med. 2024 Nov 20;24(1):575. doi: 10.1186/s12890-024-03349-3.
8
The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?卡介苗与新型冠状病毒:它们之间会存在有益关系吗?
Heliyon. 2024 Sep 19;10(18):e38085. doi: 10.1016/j.heliyon.2024.e38085. eCollection 2024 Sep 30.
9
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.COVID-19 患者中分泌自身抗体的浆母细胞的克隆景观。
Life Sci Alliance. 2024 Sep 17;7(12). doi: 10.26508/lsa.202402774. Print 2024 Dec.
10
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.SARS-CoV-2 核衣壳蛋白并非补体凝集素途径过度激活的原因。
Int J Mol Sci. 2024 Jul 4;25(13):7343. doi: 10.3390/ijms25137343.
ORF8 和 ORF3b 抗体是 SARS-CoV-2 早期和晚期感染的准确血清学标志物。
Nat Immunol. 2020 Oct;21(10):1293-1301. doi: 10.1038/s41590-020-0773-7. Epub 2020 Aug 17.
4
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.针对 SARS-CoV-2 刺突受体结合域和核衣壳的异源抗体及其对 COVID-19 免疫的影响。
JCI Insight. 2020 Sep 17;5(18):142386. doi: 10.1172/jci.insight.142386.
5
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.免疫补体和凝血功能障碍与 SARS-CoV-2 感染的不良结局。
Nat Med. 2020 Oct;26(10):1609-1615. doi: 10.1038/s41591-020-1021-2. Epub 2020 Aug 3.
6
COVID-19: Complement, Coagulation, and Collateral Damage.COVID-19:补体、凝血与附带损伤。
J Immunol. 2020 Sep 15;205(6):1488-1495. doi: 10.4049/jimmunol.2000644. Epub 2020 Jul 22.
7
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.从 COVID-19 患者中分离出具有强大接近种系 SARS-CoV-2 中和抗体的纵向研究。
Cell. 2020 Aug 20;182(4):843-854.e12. doi: 10.1016/j.cell.2020.06.044. Epub 2020 Jul 13.
8
Potently neutralizing and protective human antibodies against SARS-CoV-2.强效中和和保护 SARS-CoV-2 的人源抗体。
Nature. 2020 Aug;584(7821):443-449. doi: 10.1038/s41586-020-2548-6. Epub 2020 Jul 15.
9
Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.SARS-CoV-2 核衣壳蛋白的结构与自组装。
Protein Sci. 2020 Sep;29(9):1890-1901. doi: 10.1002/pro.3909. Epub 2020 Aug 6.
10
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.